Assessing the psychedelic "after-glow" in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; none of the 77 sources its claims cite is checked for support yet.
Abstract
Background: Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures. Methods: Using 1H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose. Results: Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later. Conclusions: These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.
Overview
CoChat Summary
## TL;DR
In 16 healthy volunteers, a single ayahuasca dose was followed within 24 hours by posterior cingulate cortex neurometabolic decreases and increased functional connectivity between cingulate and limbic/default-mode-related regions. These post-acute neural changes were associated with higher mindfulness/self-compassion scores, with some correlations persisting at 2 months.
## Key findings
- In the posterior cingulate cortex (PCC), post-acute spectroscopy showed significant decreases in creatine (Cr) and N-acetylaspartate+N-acetylaspartylglutamate (NAA-NAAG), and a decrease in glutamate+glutamine (Glx) that was significant before correction but only marginal after FDR correction (P=.041; FDR P=.068).
- Functional connectivity increased post-acute between the PCC and anterior cingulate cortex (ACC), and between the ACC and limbic structures in the right medial temporal lobe; no areas showed decreased connectivity in the second-level analysis.
- Mindfulness-related scores increased post-acute: FFMQ nonjudging [t(15) = -2.92, P=.011, FDR=.021], nonreacting [t(15) = -2.61, P=.020, FDR=.031], EQ [t(15) = -3.58, P=.003, FDR=.011], Mindsens [t(15) = -3.63, P=.002, FDR=.011], and self-compassion [t(15) = -3.00, P=.009, FDR=.020].
- Exploratory correlations linked PCC Glx decreases with nonjudging increases (n=12; r=-0.589; P=.044), and ACC connectivity increases with nonjudging, nonreacting, and self-compassion scores; at 2 months, PCC Glx decreases and ACC connectivity increases still correlated with nonjudging change.
## Methods
- Open-label, uncontrolled pre/post study of 16 healthy volunteers (6 females) with prior ayahuasca experience; exclusion criteria included psychiatric disorders, substance dependence, significant illness, and pregnancy.
- Participants completed MRI-based assessments before ayahuasca and within 24 hours after intake, plus a 2-month questionnaire follow-up for 14/16 participants.
- Main analyses included repeated-measures ANOVA for MR spectroscopy metabolites, paired-samples t tests for mindfulness scores, and seed-to-voxel resting-state functional connectivity analyses with paired-samples t tests; correlations were exploratory and uncorrected for multiple comparisons.
## Limitations
- The paper states the study was small, open-label, and uncontrolled, with no placebo or time-effect control; it also recommends larger samples and double-blind, placebo-controlled designs.
- The paper states Glx quantification was available only in a smaller subset, and that the correlation analyses were exploratory and should be interpreted with caution.
- Evident from the text: all participants had prior ayahuasca experience and baseline mindfulness scores were already high, which may limit generalizability and create ceiling effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 46 Not checked · 97 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Post-acute neural changes predicted sustained elevations in nonjudging 2 months later.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Glutamate+glutamine reductions correlated with increases in the “nonjudging” subscale of the Five Facets Mindfulness Questionnaire.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
68 more claims
Create a free account to see all 143 claims and to verify the 77 references still open.
- The quote only partly states this claim. 2
- It may state two separate claims as one. 36
- Probably not a substantial claim. 50
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the field of psychedelic neuroscience, reduced mPFC-PCC connectivity as well as DMN deactivation and disintegration have been demonstrated post-acutely after the administration of psilocybin, LSD and ayahuasca (45, 46, 57), while long-term ayahuasca users demonstrated thinning of the PCC (117).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, several studies have found positive associations between ayahuasca use and emotional acceptance processes, which appears to support the acute processing of previously avoided emotions and use of healthy emotion regulation strategies (Domínguez-Clavé et al., 2019; Franquesa et al., 2018; Sampedro et al., 2017; Soler et al., 2016, 2018).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Sampedro et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have also demonstrated the capacity of various psychedelics to enhance trait mindfulness post-acutely, even in the absence of a theoretical or practical context of mindfulness training, evidencing a complementary relationship between mindfulness-training and psychedelics (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, enhanced acceptance towards present-moment thoughts and emotions has been observed post-acutely following the administration of ayahuasca and 5-MeO-DMT, which was maintained for up to 1 month (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spontaneous enhancements in trait mindfulness have also been reported following the administration of various psychedelics, even outside of a mindfulness-enhancing context (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“F(1,12)=3.88, P=.075”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Results > MR Spectroscopy: Neurometabolite Assessment
Reported p = .075 · recomputed p = .072
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upF(1, 12) = 3.88reported p = .075 · recomputed p = .072
“F(1,12)=3.88, p = .075”
- Not confirmedF(4, 48) = 0.55reported p = .606 · recomputed p = .700
“F(4,48)=0.55, p = .606”
- Not confirmedF(4, 44) = 0.54reported p = .632 · recomputed p = .707
“F(4,44)=0.54, p = .632”
- ConsistentF(4, 44) = 761reported p < .001 · recomputed p < .001
“F(4,44)= 761, p < .001”
- ConsistentF(4, 44) = 4.11reported p < .023 · recomputed p = .006
“F(4,44)=4.11, p < .023”
10 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
The human brain is intrinsically organized into dynamic, anticorrelated functional networks
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504136102 · Cited by 8,553
Conn : A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Whitfield-Gabrieli, S., & Nieto-Castanon, A. (2012) · Brain Connectivity · doi:10.1089/brain.2012.0073 · Cited by 4,885
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Self-citationBrewer, J. A., Worhunsky, P. D., Gray, J. R., Tang, Y.-Y., Weber, J., & Kober, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112029108 · Cited by 1,409 · cited 1×
“, 2014a), a population that also shows a pattern of decreased DMN-TPN anticorrelation (Brewer et al., 2011; Froeliger et al., 2012).”
BackgroundPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 1×
“Psychedelics are the object of renewed interest as potential therapeutic tools in psychiatry (Sessa, 2005; Vollenweider and Kometer, 2010; Grob et al., 2011).”
BackgroundNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 1×
“MRS showed neurometabolic changes in the PCC, a region rich in 5-HT2A receptors (Carhart-Harris et al., 2012; Beliveau et al., 2016) and a target region of psychedelics (Palhano-Fontes et al., 2015; Carhart-Harris et al., 2016a; Valle et al., 2016).”
BackgroundSelf-citationPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Research works printed but not linked: 1
- 2014, Assessing decentering: validation, psychometric properties and clinical usefulness of the Experiences Questionnaire in a Spanish sample, Behav Ther, 45, 863, 10.1016/j.beth.2014.05.004 · DOI · Paper page
Cited by
Items 101–200 of 204
Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
Bagdasarian, F. A., Hansen, H. D., Chen, J. E., Yoo, C., Placzek, M. S., Hooker, J. M., & Wey, H. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00245 · Cited by 16
Utilizing Psychedelics to Enhance Well-Being: A Systematic Review
Thomson, S., & Thomacos, N. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2484380 · Cited by 16
Ramaekers, J. G., Mallaroni, P., Kloft, L., Reckweg, J. T., Toennes, S. W., van Oorsouw, K. I. M., & Mason, N. L. (2023) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_02003 · Cited by 16
Sanchez, T. A., Ramos, L. R., Araujo, F., Schenberg, E. E., Yonamine, M., Lobo, I., de Araújo, D. B., & Luna, L. E. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117430 · Cited by 16
Self-citationRuffell, S., Gandy, S., Tsang, W., Lopez, R., O’Rourke, N., Akhtar, A., Netzband, N., Hollingdale, J., Perkins, D., & Sarris, J. J. (2024) · Drug Science Policy and Law · doi:10.1177/20503245241235100 · Cited by 14
Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies
Chambers, R., Stoliker, D., & Simonsson, O. (2023) · Mindfulness · doi:10.1007/s12671-023-02206-4 · Cited by 16
Ayahuasca and Childhood Trauma: Potential Therapeutic Applications
Perkins, D., & Sarris, J. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_6 · Cited by 15
Psychedelics and psychological strengths
Brasher, T. J., Rosen, D., & Spinella, M. (2023) · International Journal of Wellbeing · doi:10.5502/ijw.v13i1.2325 · Cited by 10
The influence of context on ayahuasca experiences: An analysis of experience reports
Sapoznikow, A., Walsh, Z., Tupper, K. W., Erowid, E., & Erowid, F. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.028 · Cited by 10
Cortical structural differences following repeated ayahuasca use hold molecular signatures
Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K. I. M., & Ramaekers, J. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1217079 · Cited by 9
Rougemont-Bücking, A., Guenot, F., Salamin, V., Gothuey, I., Duffour, C., King-Olivier, J., Girard, V., & Naudin, J. (2024) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2024.100431 · Cited by 9
A role for enhanced functions of sleep in psychedelic therapy?
Froese, T., Leenen, I., & Páleníček, T. (2018) · Adaptive Behavior · doi:10.1177/1059712318762735 · Cited by 8
Ramos, L., & Vicente, S. (2024) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2024.2363343 · Cited by 8
What fMRI studies say about the nature of the psychedelic effect: a scoping review
Beneš, M., Páleníček, T., & Horáček, J. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1606798 · Cited by 9
Stocker, K., Hartmann, M., Reissmann, S., Kist, A., & Liechti, M. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916641 · Cited by 7
Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies
Santos, G. H. D. M., Rodrigues, L. S., Rocha, J. M., Rossi, G. N., Oña, G., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2023) · Psychoactives · doi:10.3390/psychoactives2010006 · Cited by 9
Self-citationSabucedo, P., Andión, O., Neimeyer, R. A., Soto-Angona, O., Javkin, J., Haro, J. M., Farré, M., & González, D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1484736 · Cited by 6
The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder
Pagni, B. A., Wong, J. M., & Bogenschutz, M. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00581-z · Cited by 8
Majić, T., Schmidt, T. T., Gröticke, A., Gasser, P., Richards, W. A., Riemer, T., & Evens, R. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251326937 · Cited by 7
David, J., Berkovich‐Ohana, A., & Dor‐Ziderman, Y. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06792-0 · Cited by 6
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects
Rieser, N. M., Schmidt, T. T., & Preller, K. H. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_507 · Cited by 6
The Varieties of Psychedelic Epistemology
Letheby, C. (2019) · UWA Profiles and Research Repository (UWA) · Cited by 7
Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy
Walton, C. C., & Liknaitzky, P. (2020) · Journal of Applied Sport Psychology · doi:10.1080/10413200.2020.1848941 · Cited by 6
Kupferberg, A., & Hasler, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1372650 · Cited by 7
Associations between psychedelic-related and meditation-related variables: A longitudinal study
Simonsson, O., Chaturvedi, S., Hendricks, P. S., Stenfors, C. U. D., Osika, W., Narayanan, J., Palitsky, R., & Goldberg, S. B. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.03.025 · Cited by 5
Vilca-Melendez, S., Uthaug, M. V., & Griffin, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.742856 · Cited by 5
Soto-Angona, Ó., Andión, Ó., Sabucedo, P., Neimeyer, R. A., Haro, J. M., Javkin, J., Farré, M., & González, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-13251-5 · Cited by 5
Learning as the unifying mechanism of psychedelic action
Caulfield, A., Young, A. H., & Mehta, M. A. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251405683 · Cited by 4
Bender, D. A., & Siegel, J. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00043-9 · Cited by 4
Low, Z. X. B., Yong, S. J., AlRasheed, H. A., Al‐Subaie, M. F., Kaabi, N. A., Alfaresi, M. S., Albayat, H., Alotaibi, J., bshabshe, A. A. A. A., Alwashmi, A. S. S., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111279 · Cited by 4
Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
Zeller, M. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2362284 · Cited by 6
Uthaug, M. V. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200624mu · Cited by 5
Managing Psychological Challenges in the Subacute (“Afterglow”) Window of Psychedelic Drug Effects
Evens, R., Uyar, A., & Majić, T. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_612 · Cited by 3
Haupt, M. J., Carra, S., Boehnke, K. F., & Aday, J. S. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111634 · Cited by 3
Aicher, H., Wicki, I. A., Meling, D., Mueller, M. J., Dornbierer, D., & Scheidegger, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251344689 · Cited by 3
Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes
Mason, N. L., & Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_7 · Cited by 4
Self-perception and self-recognition while looking in the mirror on psilocybin
Elias, S., Spivak, S., Alverez, A., Olivares, A. G., Ferrol, M., & Keenan, J. P. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00251 · Cited by 3
Neurobiologie und Wirkmodelle zu Psychedelika
Herwig, U., Avram, M., Borgwardt, S., & Aicher, H. (2024) · Nervenheilkunde · doi:10.1055/a-2261-0745 · Cited by 3
Donfrancesco, R., Vezzani, C., Pinto, G., Bigozzi, L., Dibenedetto, A., Melegari, M. G., Gregori, P., Andriola, E., Roma, F. D., Renzi, A., et al. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01343 · Cited by 4
The role of ceremonial ayahuasca use and the healing of eating disorders: a qualitative study
Renelli, M. (2018) · Lu Zone Ul (Laurentian University) · Cited by 10
Egger, K., Meling, D., Polat, F., Seifritz, E., Avram, M., & Scheidegger, M. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.907 · Cited by 3
Lima, G., Soares, C., Teixeira, M., Pais, M. L., Cabral, C., Rijo, P. M., & Castelo-Branco, M. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-31431-1 · Cited by 2
The interplay of psychedelic use and meditation in shaping psychological well-being
Krabbe, A., Sikka, P., & Jylkkä, J. (2025) · Consciousness and Cognition · doi:10.1016/j.concog.2025.103977 · Cited by 2
Cavallaro, N. J., Rai, P., Akins, D., Soltanpour, S., Nasseef, M. T., Ortiz, R. J., Madularu, D., Kulkarni, P. P., & Ferris, C. F. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110886 · Cited by 2
Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies
Farré‐Colomés, À., Rublinetska, O., & Soto-Angona, Ó. (2026) · Discover Mental Health · doi:10.1007/s44192-026-00384-w · Cited by 3
Egger, K., Bozsak, R., Aicher, H., Sari, H., Poetzsch, S. N., Rominger, A., Martin-Soelch, C., Smallridge, J. W., Dornbierer, D., Quednow, B. B., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261454172 · Cited by 2
Chen, Y., Wang, T., Tan, Y., & Li, D. (2024) · Digital Health · doi:10.1177/20552076241249869 · Cited by 3
Dost, D., Benyamina, A., & Karila, L. (2024) · L Encéphale · doi:10.1016/j.encep.2024.02.007 · Cited by 2
Psychedelic-assisted grief therapy: a mixed-method case study
Sabucedo, P., Evans, C., Nicolson, D., Farré, M., & González, D. (2024) · Mortality · doi:10.1080/13576275.2024.2434456 · Cited by 2
Koning, E., Chaves, C., Kirkpatrick, R. H., & Brietzke, E. M. (2024) · Journal of Eating Disorders · doi:10.1186/s40337-024-01185-8 · Cited by 2
Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Dines, J. T. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00435 · Cited by 4
Neuroaesthetics of the psychedelic state
Hooper, J., Stoliker, D., Wolfe, K., & Hutchison, K. E. (2025) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2025.109238 · Cited by 3
McGovern, H. T., Wellman, N., Hutchinson, B. T., Oestreich, L., Cooper, S., Fonzo, G. A., & Doss, M. K. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07163-z · Cited by 2
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0009 · Cited by 1
Koning, E., Gamberg, S., & Keshen, A. R. (2026) · Behavioral Sciences · doi:10.3390/bs16030376 · Cited by 1
Investigating Hypo‐Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey
Arqueros, M., Soler, J., Cebolla, A., García‐Campayo, J., Domínguez‐Clavé, E., & Pascual, J. C. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70046 · Cited by 1
Self-citationCould Psychedelics Treat Neuropathic Chronic Pain?
(2023) · Neurological Sciences and Neurosurgery · doi:10.47275/2692-093x-130 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0001 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0005 · Cited by 1
dos Santos, B. C., Reis, A. K. G., Nucci, R. A. B., Campos, A. C. P., Martins, D. O., Daldegan‐Bueno, D., & Pagano, R. L. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100087 · Cited by 1
Ayahuasca no tratamento da farmacodependência à cocaína: possíveis intervenções terapêuticas?
Bruno, V. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2019.tde-09122019-185108 · Cited by 2
Soler, J., Elices, M., Domínguez‐Clavé, E., Pascual, J. C., Feilding, A., Navarro‐Gil, M., García‐Campayo, J., & Riba, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.635111 · Cited by 1
Self-citationDefence versus Development: A Theory of Defensive and Expansive Self-RegulationPreprint
Rojas‐Hernández, J. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/2a6yz · Cited by 2
SUBJECTIVE EXPERIENCES OF CLASSIC PSYCHEDELIC SUBSTANCES USERS
Bienemann, B. (2022) · doi:10.17771/pucrio.acad.59337 · Cited by 1
Orlowski, P., Ruban, A., Szczypiński, J., Hobot, J., Bielecki, M., & Bola, M. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/k4xfg
Nilsson, M. (2020) · Lund University Publications Student Papers (Lund University) · Cited by 1
Ayahuasca as a Versatile Therapeutic Agent: From Molecules to Metacognition and Back
Valle, M., Domínguez‐Clavé, E., Elices, M., Pascual, J. C., Soler, J., Morales-Garcia, J. A., Pérez‐Castillo, A., & Riba, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_1 · Cited by 1
Self-citationルポ 昼休みを生かしてリフレッシュ--東京急行電鉄(株)車両部長津田検車区 (作業の合間でリフレッシュ--休憩時間の過ごし方のヒント )
労働衛生編集部 (1995) · 労働衛生
Aharon-Almagor, A., & Barrett, F. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1529935/v1
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm · Cited by 1
Dubbini, A. (2023) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2303035
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0010
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0011
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0008
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0012
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0007
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0003
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0004
What Is Psychedelic Experience?
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0002
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0005
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0003
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023) · Pharmacotherapy in Psychiatry and Neurology · doi:10.5114/fpn.2023.131979 · Cited by 1
A Neurocognitive Framework for Psychedelics as Learning OpportunitiesPreprint
Mattek, S. (2024) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/jpck8
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00015-x
Self-citationPostakute Effekte von klassischen Psychedelika
Evens, R., & Majić, T. (2024) · Nervenheilkunde · doi:10.1055/a-2305-6591
Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness
Mian, M. N. (2019) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/1c38-bn99 · Cited by 1
Psychedelic preparation and integration through depth hypnosis spiritual counseling
Adler, J. F., & Gucciardi, I. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00451
Psychedelic biomedicalization: mainstreaming a scientific revolution
Neitzke‐Spruill, L. (2023) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/6yb4-rd10 · Cited by 2
Ramos, L. I. N. P. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/erq0-ba03
Hurwitz, E. S. (2024) · eScholarship (California Digital Library) · Cited by 4
Domínguez‐Clavé, E. (2022) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Self-citationHigh hopes? Precision psychedelic addiction medicine
Zafar, R. R., Kleine, P., Kurtin, D. L., Wall, M. B., & Erritzøe, D. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1681795
Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Araújo, D. B., Maia, L. O., Sanchez, T. A., Coelho, N. L. G., & Palhano-Fontes, F. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00721-7
Bouso, J. C., Andión, Ó., Cantillo, J., Pérez, I. H., Farré, M., Obiols, J. E., & González, D. (2026) · Psychedelics · doi:10.1016/j.psyche.2026.100018
Mallard, A. J., Broussard, M., Zeifman, R. J., Espinoza, D., Cloutier, S. A., Ross, S., Bogenschutz, M. P., & Pagni, B. A. (2026) · Journal of Humanistic Psychology · doi:10.1177/00221678261442571
Can Childhood be Used as a Model to Understand the Effects of Psychedelics?
Hurwitz, E. S., Dean, J. G., & Walker, C. M. (2026) · Topics in Cognitive Science · doi:10.1111/tops.70058
The Possibility of Simulating Psychedelic Experiences in Virtual Reality Using Psyrreal
Schihalejev, S. (2026) · DSpace repository (University of Tartu)
Aicher, H., Dornbierer, J., Caflisch, L., Suay, D., Mueller, M. J., Landolt, H., Quednow, B. B., Scheidegger, M., & Dornbierer, D. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07118-4
Metadata
- Authors
- Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., Friedlander, P., Barker, S. A., Álvarez, E., Soler, J., Pascual, J. C., Feilding, A., & Riba, J.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-13
- Volume
- 20
- Issue
- 9
- Pages
- 698-711
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5581489
- OpenAlex
- W2616273018
- Semantic Scholar
- b0995e4954d6fef2bf65bfd7d47bd21f6087bd23
- Cited by
- 200
- References
- 74
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 26 · 2023: 35 · 2022: 27 · 2021: 32 · 2020: 18 · 2019: 14 · 2018: 11 · 2017: 1
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- Beckley Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- ayahuasca, psychedelics, mindfulness, non-judgment, self-compassion, posterior cingulate cortex, anterior cingulate cortex, medial temporal lobe, default mode network, glutamate, neurometabolites, functional connectivity, N,N-dimethyltryptamine, harmala alkaloids, antidepressant effects
- MeSH terms
- Adult, Aspartic Acid, Brain Mapping, Cerebral Cortex, Female, Follow-Up Studies, Hallucinogens, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Surveys and Questionnaires, Time Factors, Glutamic Acid, Imaging, Three-Dimensional, Banisteriopsis, Healthy Volunteers, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.